000 01445 a2200433 4500
005 20250517005657.0
264 0 _c20151201
008 201512s 0 0 eng d
022 _a1744-8379
024 7 _a10.1586/14737167.2015.990888
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aPearce, Alison
245 0 0 _aCan administrative data be used to measure chemotherapy side effects?
_h[electronic resource]
260 _bExpert review of pharmacoeconomics & outcomes research
_cApr 2015
300 _a215-22 p.
_bdigital
500 _aPublication Type: Journal Article; Observational Study; Research Support, Non-U.S. Gov't
650 0 4 _aAdult
650 0 4 _aAged
650 0 4 _aAged, 80 and over
650 0 4 _aAntineoplastic Agents
_xadverse effects
650 0 4 _aCohort Studies
650 0 4 _aData Collection
_xmethods
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aMale
650 0 4 _aMiddle Aged
650 0 4 _aModels, Economic
650 0 4 _aSelf Report
650 0 4 _aYoung Adult
700 1 _aHaas, Marion
700 1 _aViney, Rosalie
700 1 _aHaywood, Philip
700 1 _aPearson, Sallie-Anne
700 1 _avan Gool, Kees
700 1 _aSrasuebkul, Preeyaporn
700 1 _aWard, Robyn
773 0 _tExpert review of pharmacoeconomics & outcomes research
_gvol. 15
_gno. 2
_gp. 215-22
856 4 0 _uhttps://doi.org/10.1586/14737167.2015.990888
_zAvailable from publisher's website
999 _c24448080
_d24448080